These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840 [TBL] [Abstract][Full Text] [Related]
3. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Tilg H; Moschen AR Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136 [TBL] [Abstract][Full Text] [Related]
4. The role of cytokines in non-alcoholic fatty liver disease. Tilg H Dig Dis; 2010; 28(1):179-85. PubMed ID: 20460908 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease. Schäffler A; Schölmerich J; Büchler C Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231 [TBL] [Abstract][Full Text] [Related]
6. [Adipocytokines as mediators of metabolic role of adipose tissue]. Pandzić Jaksić V Acta Med Croatica; 2010 Oct; 64(4):253-62. PubMed ID: 21688608 [TBL] [Abstract][Full Text] [Related]
7. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Koerner A; Kratzsch J; Kiess W Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):525-46. PubMed ID: 16311215 [TBL] [Abstract][Full Text] [Related]
12. Adipocytokines - novel link between inflammation and vascular function? Guzik TJ; Mangalat D; Korbut R J Physiol Pharmacol; 2006 Dec; 57(4):505-28. PubMed ID: 17229978 [TBL] [Abstract][Full Text] [Related]
13. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426 [TBL] [Abstract][Full Text] [Related]
14. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Iglesias P; Díez JJ Cytokine; 2007 Nov; 40(2):61-70. PubMed ID: 18006329 [TBL] [Abstract][Full Text] [Related]
15. A new frame in thromboembolic cardiovascular disease: Adipocytokine. Amasyali B; Kilic A; Celik T; Iyisoy A Int J Cardiol; 2010 Feb; 139(1):100-2. PubMed ID: 18723235 [TBL] [Abstract][Full Text] [Related]
16. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. Tilg H Curr Pharm Des; 2010 Jun; 16(17):1893-5. PubMed ID: 20370678 [TBL] [Abstract][Full Text] [Related]
17. Obesity, adipokines and hepatocellular carcinoma. Duan XF; Tang P; Li Q; Yu ZT Int J Cancer; 2013 Oct; 133(8):1776-83. PubMed ID: 23404222 [TBL] [Abstract][Full Text] [Related]
18. The promoting effect of adiponectin in hepatocellular carcinoma. Chen MJ; Yeh YT; Lee KT; Tsai CJ; Lee HH; Wang SN J Surg Oncol; 2012 Aug; 106(2):181-7. PubMed ID: 22287480 [TBL] [Abstract][Full Text] [Related]
19. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer. Rajesh Y; Sarkar D Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547 [TBL] [Abstract][Full Text] [Related]
20. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]